Studying Multi-Target Drug Approaches and Posttranslational Modification (PTM) Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 744
Special Issue Editor
2. National Engineering Research Center for Non-Food Biorefinery, Guangxi Academy of Sciences, Chinese Academy of Agriculture Science, Nanning 530004, China
Interests: biomolecular interactions; structures and functions of biomolecules; nuclear magnetic resonance (NMR); X-ray crystallography; bioinformatics; artificial intelligence (AI); machine learning (ML); deep learning (DL); molecular dynamics simulation (MDS)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Multi-target therapy is the favoured pathway for achieving desired treatment effects in cancer and nervous system, cardiovascular system, and immune system diseases. Network analysis tools and computational prediction approaches have been incorporated into research of the basic mechanisms of these diseases. These computational approaches are novel, and are closely associated with the identification of the subcellular localization of so-called “multi-label” proteins. Recently, user-friendly web-server predictors have been established, whereby users can easily attain their desired results for multi-label proteins in eukaryotic, human, animal, plant, Gram-positive, and Gram-negative organisms, respectively. Posttranslational modifications (PTMs) are related to a number of diseases. In order to obtain targets’ 3D structures for rational drug design in a timely and accurate manner, both theoretical and experimental approaches of structural biology are used. Certain intermolecular and intramolecular interactions related to the migration and invasion of tumor cells may occur during the PTM process. In this Special Issue, recent advances in studying multi-target therapies and PTM will be collected. These studies may provide new perspectives on drug research and development related to tumor-targeted enzymes.
This Special Issue is supervised by Prof. Dr. Guo-Ping Zhou and assisted by our Guest Editor’ assistant editor Dr. Bo Lu, Lubo45@126.com (Institute of Biological Science and Technology, Guangxi Academy of Sciences).
Prof. Dr. Guo-Ping Zhou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multi-target therapy
- network analysis tools
- multi-label proteins
- web-server predictor
- posttranslational modifications (PTMs)
- 3D structures
- rational drug design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
